The 3-deoxy analogue of α-GalCer: Disclosing the role of the 4-hydroxyl group for CD1d-mediated NKT Cell activation

ACS Medicinal Chemistry Letters

Volumn 2, Issue 7, 2011, Pages 544-548

  Baek, Dong Jae ^a   Seo, Jeong Hwan ^a   Lim, Chaemin ^a   Kim, Jae Hyun ^a   Chung, Doo Hyun ^a   Cho, Won Jea ^b   Kang, Chang Yuil ^a   Kim, Sanghee ^a  

^a Seoul National University   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

GalCer; CD1d; deoxy analogues; glycolipid; natural killer T cells; T cell receptor

Indexed keywords

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; GLYCOLIPID; T LYMPHOCYTE RECEPTOR;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR DOCKING; NATURAL KILLER T CELL; PRIORITY JOURNAL;

EID: 79960422121     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml2000802     Document Type: Article

References (32)

1. Morita, M.; Motoki, K.; Akimoto, K.; Natori, T.; Sakai, T.; Sawa, E.; Yamaji, K.; Koezuka, Y.; Kobayashi, E.; Fukushima, H. Structure-activity relationship of α-galactosylceramides against B16-bearing mice J. Med. Chem. 1995, 38, 2176-2187
2. Tupin, E.; Kinjo, Y.; Kronenberg, M. The unique role of natural killer T cells in the response to microorganisms Nat. Rev. Microbiol. 2007, 5, 405-417 (Pubitemid 46780078)
3. Balato, A.; Unutmaz, D.; Gaspari, A. A. Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions J. Invest. Dermatol. 2009, 129, 1628-1642
4. Cerundolo, V.; Silk, J. D.; Masri, S. H.; Salio, M. Harnessing invariant NKT cells in vaccination strategies Nat. Rev. Immunol. 2009, 9, 28-38
5. Banchet-Cadeddu, A.; Hénon, E.; Dauchez, M.; Renault, J.-H.; Monneaux, F.; Haudrechy, A. The stimulating adventure of KRN 7000 Org. Biomol. Chem. 2011, 9, 3080-3104
6. Mori, K.; Tashiro, T. Sphingolipids and glycosphingolipids-Their syntheses and bioactivities Heterocycles 2011, 83, 951-1003
7. Kronenberg, M. Toward an understanding of NKT cell biology: Progress and Paradoxes Annu. Rev. Immunol. 2005, 23, 877-900 (Pubitemid 40563188)
8. Kaer, L. V. α-Galactosylceramide therapy for autoimmune diseases: Prospects and obstacles Nat. Rev. Immunol. 2005, 5, 31-42
9. Murphy, N.; Zhu, X.; Schmidt, R. R. α-Galactosylceramides and analogues-Important immunomodulators for use as vaccine adjuvants Carbohydr. Chem. 2010, 36, 64-100
10. Zajonc, D. M.; Cantu, C., III; Mattner, J.; Zhou, D.; Savage, P. B.; Bendelac, A.; Wilson, I. A.; Teyton, L. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor Nat. Immunol. 2005, 6, 810-818 (Pubitemid 43090467)
11. Koch, M.; Stronge, V. S.; Shepherd, D.; Gadola, S. D.; Mathew, B.; Ritter, G.; Fersht, A. R.; Besra, G. S.; Schmidt, R. R.; Jones, E. Y.; Cerundolo, V. The crystal structure of human CD1d with and without α-galactosylceramide Nat. Immunol. 2005, 6, 819-826 (Pubitemid 43090468)
12. Borg, N. A.; Wun, K. S.; Kjer-Nielsen, L.; Wilce, M. C. J.; Pellicci, D. G.; Koh, R.; Besra, G. S.; Bharadwaj, M.; Godfrey, D. I.; McCluskey, J.; Rossjohn, J. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor Nature 2007, 448, 44-49 (Pubitemid 47037002)
13. Pellicci, D. G.; Patel, O.; Kjer-Nielsen, L.; Pang, S. S.; Sullivan, L. C.; Kyparissoudis, K.; Brooks, A. G.; Reid, H. H.; Gras, S.; Lucet, I. S.; Koh, R.; Smyth, M. J.; Mallevaey, T.; Matsuda, J. L.; Gapin, L.; McCluskey, J.; Godfrey, D. I.; Rossjohn, J. Differential Recognition of CD1d-α- GalactogylCeramide by the Vβ8.2 and Vβ7 semi-invariant NKT T cell receptors Immunity 2009, 31, 47-59
14. Goff, R. D.; Gao, Y.; Mattner, J.; Zhou, D.; Yin, N.; Cantu, C., III; Teyton, L.; Bendelac, A.; Savage, P. B. Effects of lipid chain lengths in α-galactosylceramides on cytokine release by natural killer T cells J. Am. Chem. Soc. 2004, 126, 13602-13603 (Pubitemid 39407224)
15. Tsuji, M. Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands Cell. Mol. Life Sci. 2006, 63, 1889-1898
16. Savage, P. B.; Teyton, L.; Bendelac, A. Glycolipids for natural killer T cells Chem. Soc. Rev. 2006, 35, 771-779 (Pubitemid 44286272)
17. Wu, D.; Fujio, M.; Wong, C.-H. Glycolipids as immunostimulating agents Bioorg. Med. Chem. 2008, 16, 1073-1083 (Pubitemid 351191755)
18. Nadas, J.; Li, C.; Wang, P. G. Computaional structure activity relationship studies on the CD1d/glycolipid/TCR complex using AMBER and AUTODOCK J. Chem. Inf. Model. 2009, 49, 410-423
19. Lacône, V.; Hunault, J.; Pipelier, M.; Blot, V.; Lecourt, T.; Rocher, J.; Turcot-Dubois, A.-L.; Marionneau, S.; Douillard, J.-Y.; Clément, M.; Le Pendu, J.; Bonneville, M.; Micouin, L.; Dubreuil, D. Focus on the controversial activation of human iNKT cells by 4-deoxy analogue of KRN7000 J. Med. Chem. 2009, 52, 4960-4963
20. Ndonye, R. M.; Izmirian, D. P.; Dunn, M. F.; Yu, K. O. A.; Porcelli, S. A.; Khurana, A.; Kronenberg, M.; Richardson, S. K.; Howell, A. R. Synthesis and evaluation of sphinganine analogues of KRN7000 and OCH J. Org. Chem. 2005, 70, 10260-10270 (Pubitemid 41759895)
21. α14 i NKT cells has a unique mode of glycosphingolipid antigen recognition Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 12254-12259 (Pubitemid 39145430)
22. H2 bias of natural killer T cells Nature 2001, 413, 531-534 (Pubitemid 32938752)
23. Wu, D.; Zajonc, D. M.; Fujio, M.; Sullivan, B. A.; Kinjo, Y.; Kronenberg, M.; Wilson, I. A.; Wong, C.-H. Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 3972-3977
24. Trappeniers, M.; Goormans, S.; Beneden, K. V.; Decruy, T.; Linclau, B.; Al-Shamkhani, A.; Elliott, T.; Ottensmeier, C.; Werner, J. M.; Elewaut, D.; Van Calenbergh, S. Synthesis and in vitro evaluation of α-GalCer epimers ChemMedChem 2008, 3, 1061-1070
25. Mukaiyama, T.; Murai, Y.; Shoda, S. An efficient method for glucosylation of hydroxy compounds using glucopyranosyl fluoride Chem. Lett. 1981, 431-432
26. Du, W.; Kulkarni, S. S.; Gervay-Hague, J. Efficient, one-pot syntheses of biologically active α-linked glycolipids Chem. Commun. 2007, 2336-2338 (Pubitemid 46889434)
27. Alper, P. B.; Hung, S.-C.; Wong, C.-H. Metal catalyzed diazo transfer for the synthesis of azides from amines Tetrahedron Lett. 1996, 37, 6029-6032 (Pubitemid 26259506)
28. Nishida, Y.; Shingu, Y.; Dohi, H.; Kobayashi, K. One-pot α-glycosylation method using appel agents in N, N -dimethylformamide Org. Lett. 2003, 5, 2377-2380 (Pubitemid 37140863)
29. Kim, S.; Song, S.; Lee, T.; Jung, S.; Kim, D. Practical Synthesis of KRN7000 from phytosphinghosine Synthesis 2004, 847-850
30. Zhou, D.; Mattner, J.; Cantu, C., III; Schrantz, N.; Yin, N.; Gao, Y.; Sagiv, Y.; Hudspeth, K.; Wu, Y.-P.; Yamashita, T.; Teneberg, S.; Wang, D.; Proia, R. L.; Levery, S. B.; Savage, P. B.; Teyton, L.; Bendelac, A. Lysosomal glycosphingolipid recognition by NKT cells Science 2004, 306, 1786-1789 (Pubitemid 39601398)
31. For selected examples for other computational studies in the α-GalCer analogues, see Zhang, W.; Xia, C.; Nadas, J.; Chen, W.; Gu, L.; Wang, P. G. Introduction of aromatic group on 4′-OH of α-GalCer manipulated NKT cell cytokine production Bioorg. Med. Chem. 2011, 19, 2767-2776. Also see refs 33 and 18
32. Hénon, E.; Dauchez, M.; Haudrechy, A.; Banchet, A. Molecular dynamics simulation study on the interaction of KRN 7000 and three analogues with human CD1d Tetrahedron 2008, 64, 9480-9489